ClinConnect ClinConnect Logo
Search / Trial NCT06350760

Transdiagnostic, Indicated Preventive Intervention for Adolescents At High Risk of Emotional Problems W/Add-On Modules

Launched by UNIVERSITY OF JAÉN · Apr 1, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Transdiagnostic Emotional Disorders Anxiety Depression Adolescents Child And Youth Population Indicated Prevention

ClinConnect Summary

This clinical trial, called PROCARE, is exploring a preventive program designed to help teenagers who are at a high risk of developing emotional issues, such as anxiety and depression. The goal is to see if this online, personalized intervention can improve their emotional well-being and identify any risk factors that might predict these symptoms. In this study, 30 adolescents with early signs of anxiety or depression will participate in the program, and researchers will compare their emotional state before and after the intervention to assess its effectiveness.

To be eligible for this trial, participants need to be between the ages of 4 and 18 and show signs of anxiety or depression, but they should not have a diagnosed mood disorder. They must also be able to attend prevention sessions independently and understand the program's language. Participants will engage in the PROCARE program and can expect to receive support aimed at improving their emotional health and overall quality of life. It's important to note that this study does not include individuals currently undergoing psychological treatment or those with severe emotional issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • written informed consent from adolescent and legal guardian
  • able to attend prevention modules on his/her own
  • language competence
  • Strengths and Difficulties Questionnaire ""probable diagnoses"
  • score above cut-off for Revised Child Anxiety and Depression Scale-30
  • having incipient symptoms on an emotional level in ADIS 5 C/P
  • absence of anxiety and/or mood disorders
  • Exclusion Criteria:
  • in- or outpatient
  • concomitant psychological/psychiatric treatment
  • acute suicidality
  • general medical contraindications that hamper attendance to prevention modules
  • have been diagnosed with a neurodevelopmental disorder
  • Strengths and Difficulties Questionnaire "unlikely" or "possible diagnoses"
  • presence of mood and/or anxiety disorders

About University Of Jaén

The University of Jaén, a leading academic institution in Spain, is dedicated to advancing health research through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medicine, biology, and pharmacology to contribute to the development of novel therapeutic interventions. Committed to ethical research practices and patient safety, the University of Jaén fosters a rigorous scientific environment that aims to translate research findings into tangible health benefits for the community.

Locations

Elche, Alicante, Spain

Tarragona, , Spain

Jaén, , Spain

Jaén, Jaen, Spain

Patients applied

0 patients applied

Trial Officials

Luis Joaquín García-López, Ph. D.

Principal Investigator

University of Jaén

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported